REQUEST A DEMO
Total
USD $0.00
Search more companies

Lekaren Pri Buducnosti, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Lekaren Pri Buducnosti, S.R.O. Profile Updated: October 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Lekaren Pri Buducnosti, S.R.O. is an enterprise in Slovakia, with the main office in Kosice. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on July 27, 2006. The total number of employees is currently 5 - 9 (2025). From the latest financial highlights, Lekaren Pri Buducnosti, S.R.O. reported a net sales revenue increase of 11.09% in 2025. Over the same period, its total assets decreased by 0.44%. The net profit margin of Lekaren Pri Buducnosti, S.R.O. increased by 0.25% in 2025.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Lekaren Pri Buducnosti, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Lekaren Pri Buducnosti, S.R.O. report to view the information.
Registered Capital:
Purchase the Lekaren Pri Buducnosti, S.R.O. report to view the information.
Financial Auditors:
Purchase the Lekaren Pri Buducnosti, S.R.O. report to view the information.
Incorporation Date:
July 27, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lekaren Pri Buducnosti, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.09%
Total Operating Revenue
11.11%
Operating Profit
30.79%
EBITDA
16.14%
Net Profit/Loss for the Period
28.79%
Total Assets
-0.44%
Total Equity
18.6%
Operating Profit Margin
0.32%
Net Profit Margin
0.25%
Return on Equity (ROE)
1.24%
Debt / Equity
-0.26%
Quick Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?